PORTERFIELD, FETTIG & SEARS, LLC

Lobbying for TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceuticals

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Illinois · House · Senate · $50,000.00 income · posted Jul 18, 2025

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 2

Health Issues

General issues related to drug research and innovation; issues related to the Congressional Plasma Caucus.

Taxation/Internal Revenue Code

Issues related to global taxes, specifically Section 899 of H.R. 1.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.